Recursion raises $200M, reports trial data for two drug candidates

🌐 Investing.com (Cyprus) —
Recursion raises $200M, reports trial data for two drug candidates

AI Summary

Biotechnology company Recursion raised $200 million and reported trial data for two drug candidates. The headline does not specify the candidates, trial results, or funding terms.

Markets Deals Health Recursion biotechnology fundraising $200 million clinical trials drug candidates

Read original source →